title: New oral anticoagulants.
authors.affiliation: Department of Medicine, University of Western Ontario, London, Ont.
authors.forename: Dongmei
authors.initials: D
authors.lastname: Sun
authors.forename: Alejandro
authors.initials: A
authors.lastname: Lazo-Langner
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D002170:Canada; D000075202:Contraindications; D000069604:Dabigatran; D054796:Drug Dosage Calculations; D004347:Drug Interactions; D006801:Humans; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D000069552:Rivaroxaban; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D000069552:Rivaroxaban; D000069604:Dabigatran